reviewTop 1% cited
The GABA system in anxiety and depression and its therapeutic potential
Neuropharmacology · 2011 · Vol. 62(1) · pp. 42–53
Hanns Möhler✉(ETH Zurich)
Neuroscience and Neuropharmacology ResearchTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorGABAA receptorAnxietyAntidepressantAnxiolyticNeuroscienceGABAergicPsychologyGABAB receptorPharmacologyAnxiogenic
MeSH terms
Antidepressive AgentsAnxietyDepressiongamma-Aminobutyric AcidHumansNeural PathwaysPyridazinesTriazolesReceptors, GABAGABA Agonists
Citations
579
FWCI
11.77
field-weighted impact
References
199
Percentile
99%
vs. same field & year
Citations per year
Cited by
Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches
Frontiers in Psychology · 2015 · 923 citations
References
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Biological Psychiatry · 2011 · 1,074 citations
Extinction Learning in Humans
Neuron · 2004 · 1,755 citations
Antidepressant effects of ketamine in depressed patients
Biological Psychiatry · 2000 · 3,787 citations
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
Archives of General Psychiatry · 1994 · 3,315 citations
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue.
Biological Psychiatry · 1999 · 1,481 citations
The GABAergic deficit hypothesis of major depressive disorder
Molecular Psychiatry · 2010 · 923 citations
A Neurotrophic Model for Stress-Related Mood Disorders
Biological Psychiatry · 2006 · 3,300 citations
GABAA receptors: Subtypes provide diversity of function and pharmacology
Neuropharmacology · 2008 · 965 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.